Clinical Trials Browser

Phase 2 × Mesonephric Gynecologic Cancer × 90 days × Clear all

NCT05787561 2026-03-12

A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer

Phase 2 Recruiting

Mesonephric Gynecologic Cancer